Supplements
coffee decreases Parkinson's disease risk
In plain terms: Does coffee protect against Parkinson's disease?
Part of: • Coffee
Coffee drinkers do get Parkinson's less often - studies suggest around 25-30% lower risk, likely via caffeine's effect on the brain. One honest caveat: very early Parkinson's can quietly reduce someone's taste for coffee years before diagnosis, which may make coffee look more protective than it truly is.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
People who drink coffee are consistently found to have a lower risk of Parkinson's disease — multiple meta-analyses and umbrella reviews put the risk around 25–30% lower, with the biggest effect near ~3 cups/day, anchored by the landmark Honolulu Heart cohort. The effect is thought to come from caffeine's action on brain adenosine receptors.
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Hong CT et al. 2020 · Nutrients | meta-analysis | supports | high | Meta 13 studies: regular caffeine/coffee HR 0.797 lower PD risk; also slower progression. |
| Gabbert C et al. 2024 · Mov Disord | observational | mixed | moderate | Cohort: coffee among lifestyle factors predicting later PD age-at-onset (not incidence). |
| d10-31435-ijitss-2-50-2026-5914 2026 · International Journal of Innovative Technologies in Social Science | meta-analysis | supports | moderate | Explicit systematic review of epidemiological, preclinical and mechanistic evidence on coffee constituents and neurodegeneration; reports coffee/caffeine consumption correlates with PD risk reduction with relative risk ranging 0.65-0.80 acr |
| Costa J et al. 2010 · J Alzheimers Dis | meta-analysis | supports | high | SR+meta 26 studies: summary RR 0.75; cohort-only RR 0.80. |
| Kishore A et al 2025 · study_type: observational | observational | contradicts | moderate | Pan-Indian case-control study (7918 PD cases, 3300 age/sex-matched pairs): coffee consumption OR 1.73 among PD cases, explicitly flagged as an exception to the 'previously known' protective association seen elsewhere. |
| Kuzovenkova D et al 2025 · study_type: observational | observational | contradicts | moderate | Mendelian randomization found coffee consumption causally associated with LATER age-at-onset of PD (IVW OR 1.91, 95% CI 1.53-2.38, p=8e-9), but NO causal association or genetic correlation with PD risk or progression. |
| Mentis AA et al. 2021 · Behav Brain Res | meta-analysis | supports | high | Meta-umbrella (203 meta-analyses): coffee identified as protective factor for PD. |
| Ross GW et al. 2000 · JAMA | observational | supports | high | Honolulu Heart cohort (8,004 men): PD incidence fell 10.4 to 1.9/10,000 from none to highest intake (landmark). |
| Chen JX et al. 2021 · Front Aging Neurosci | meta-analysis | supports | moderate | Overview of 46 systematic reviews: coffee/caffeine/tea significantly reduce PD risk. |
| Gabbert C et al. 2022 · J Neurol | observational | tested-null | low | Cross-sectional (36k): coffee linked to later age-at-onset (not an incidence-risk design). |
| Trezzi I et al 2026 · study_type: observational | observational | supports | low | Narrative review states 'moderate coffee consumption could reduce PD risk and progression' as part of a broader survey of diet and PD, without primary quantitative data of its own. |
| Grosso G et al. 2017 · Annu Rev Nutr | meta-analysis | supports | high | Umbrella: coffee rated probable decreased risk of Parkinson's disease. |
| Qi H, Li S 2014 · Geriatr Gerontol Int | meta-analysis | supports | high | Dose-response meta (901k): max protection ~3 cups/d, smoking-adjusted RR 0.72. |
| Zhao Y et al 2024 · study_type: observational | observational | supports | high | EPIC4PD prospective cohort (n=184,024): highest vs. no coffee intake HR 0.63 (95% CI 0.46-0.88, p=0.006) for incident PD; nested case-control (351 cases) showed prediagnostic plasma caffeine and metabolites (paraxanthine, theophylline) inve |
| Ishihara L, Brayne C 2005 · Acta Neurol Scand | meta-analysis | supports | moderate | SR (7 cohort + 33 case-control): meta supports inverse coffee-PD association. |
| Saarinen EK et al 2024 · study_type: observational | observational | mixed | moderate | In 163 early PD patients, higher habitual coffee/caffeine consumption was associated with 8.3-15.4% lower striatal dopamine transporter binding and progressive decline over 6.1 years, with no effect on motor symptoms; authors interpret this |
| Hong SW et al 2025 · study_type: mechanism | mechanism | supports | moderate | Narrative review of candidate coffee/smoking constituents (phenolics) inhibiting MAO-B, COMT, and alpha-synuclein fibrillation, proposed to underlie the epidemiological association between coffee drinking and lower PD incidence. |
| Chuang YH et al. 2016 · Parkinsonism Relat Disord | observational | supports | moderate | Case-control + meta: inverse coffee-PD strongest in ADORA2A/CYP1A2 variant carriers. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.